Kobayashi Pharmaceutical Co Ltd (4967) – Strategy, SWOT and Corporate Finance Report

Kobayashi Pharmaceutical Co Ltd (4967) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Kobayashi Pharmaceutical Co Ltd (Kobayashi) manufactures and distributes pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, eyeglasses cleaners, body warmers and cooling gel sheets for the forehead. It also offers health food products, dietary food products, nutritional supplements, skincare products, medical equipment, devices and ventilators to medical institutes and hospitals, transportation, insurance, production, advertising planning, synthetic resin products and real estate management services. The company operates through subsidiaries and has a presence in North America, Europe, and Asia. Kobayashi is headquartered in Chuo, Osaka, Japan.

Scope

• Detailed information on Kobayashi Pharmaceutical Co Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Kobayashi Pharmaceutical Co Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Kobayashi Pharmaceutical Co Ltd including a breakdown and examination of key business segments

• News about Kobayashi Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Kobayashi Pharmaceutical Co Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Kobayashi Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Kobayashi Pharmaceutical Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Daiichi Sankyo Co Ltd

Tsumura & Co

Seikagaku Corp

Taisho Pharmaceutical Holdings Co Ltd

Astellas Pharma Inc

Mitsubishi Tanabe Pharma Corp

Shionogi & Co Ltd

Astellas Pharma Inc

Tsumura & Co

Daiichi Sankyo Co Ltd

Seikagaku Corp

Taisho Pharmaceutical Holdings Co Ltd

Mitsubishi Tanabe Pharma Corp

Shionogi & Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Kobayashi Pharmaceutical Co Ltd - Key Facts

Kobayashi Pharmaceutical Co Ltd - Key Employees

Kobayashi Pharmaceutical Co Ltd - Key Employee Biographies

Kobayashi Pharmaceutical Co Ltd - Major Products and Services

Kobayashi Pharmaceutical Co Ltd - History

Kobayashi Pharmaceutical Co Ltd - Company Statement

Kobayashi Pharmaceutical Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Kobayashi Pharmaceutical Co Ltd - Business Description

Business Segment: Domestic Business

Overview

Performance

Business Segment: International Business

Overview

Performance

Business Segment: Mail Order Business

Overview

Performance

Business Segment: Other Businesses

Overview

Performance

R&D Overview

Kobayashi Pharmaceutical Co Ltd - Corporate Strategy

Kobayashi Pharmaceutical Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Kobayashi Pharmaceutical Co Ltd - Strengths

Kobayashi Pharmaceutical Co Ltd - Weaknesses

Kobayashi Pharmaceutical Co Ltd - Opportunities

Kobayashi Pharmaceutical Co Ltd - Threats

Kobayashi Pharmaceutical Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Kobayashi Pharmaceutical Co Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Feb 15, 2023: Kobayashi Announces Financial Overview for Fiscal Year Ended December 31, 2022

Jan 25, 2023: Released a new coronavirus antigen and influenza virus antigen qualitative simultaneous test kit (over-the-counter test reagent)

Nov 22, 2022: CDO unit (newly established) unit leader Ryo Ishido

Nov 01, 2022: Kobayashi Pharmaceutical Co Announces Financial Overview for the Third Quarter of Fiscal 2022

Oct 19, 2022: Acquisition of manufacturing and marketing approval for the novel coronavirus antigen test kit (over-the-counter test drug)

Aug 02, 2022: Japan's first! Switch OTC drug containing the medical ingredient "itopride hydrochloride"

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Kobayashi Pharmaceutical Co Ltd, Key Facts

Kobayashi Pharmaceutical Co Ltd, Key Employees

Kobayashi Pharmaceutical Co Ltd, Key Employee Biographies

Kobayashi Pharmaceutical Co Ltd, Major Products and Services

Kobayashi Pharmaceutical Co Ltd, History

Kobayashi Pharmaceutical Co Ltd, Subsidiaries

Kobayashi Pharmaceutical Co Ltd, Key Competitors

Kobayashi Pharmaceutical Co Ltd, Ratios based on current share price

Kobayashi Pharmaceutical Co Ltd, Annual Ratios

Kobayashi Pharmaceutical Co Ltd, Annual Ratios (Cont…1)

Kobayashi Pharmaceutical Co Ltd, Annual Ratios (Cont…2)

Kobayashi Pharmaceutical Co Ltd, Interim Ratios

Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Kobayashi Pharmaceutical Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Kobayashi Pharmaceutical Co Ltd, Performance Chart (2018 – 2022)

Kobayashi Pharmaceutical Co Ltd, Ratio Charts

Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports